Cardiology Search
Cardiology Cardiology
rheumatic%20fever%20-%20acute
RHEUMATIC FEVER - ACUTE
Acute rheumatic fever is an autoimmune response to a previous group A beta-hemolytic streptococcal (GAS) infection causing acute generalized anti-inflammatory response primarily affecting the heart.
It often presents in patients 5-14 years of age and uncommon before 3 years and after 21 years of age.
Patients presenting with acute rheumatic fever are severely unwell, in extreme pain and requires hospitalization.

Rheumatic Fever - Acute Drug Information

Drug Information

Indication: Mild to moderate pain & fever.

Indication: Upper & lower resp tract, GUT, skin & soft tissue infections, gonorrhoea, acute uncomplicated gonococc...

Indication: Resp tract, ENT, O&G, skin & soft tissue, bone & dental infections, UTI. Prophylaxis of recurrent ...

Axcel Erythromycin ES
erythromycin ethylsuccinate

Indication: Upper & lower resp tract infections caused by Strep pyogenes & Strep pneumoniae; pertussis caused by B...

Indication: Relief of fever associated w/ cold & flu, pain eg, teething, toothache, earache, sore throat, headache, mi...

Indication: Relief of fever & pain eg, headache, toothache, colds, flu, muscular rheumatism, dysmenorrhoea, teething p...

Indication: Rheumatic fever, RA, allergic diseases, nephritic syndrome, bronchial asthma & other corticosteroid-indica...

Indication: Relief of painful & febrile conditions eg, headache, migraine, backache, toothache, aches due to cold &...

Indication: Lower & upper rest tract, skin & soft tissue infections, acute otitis media. STD, uncomplicated genita...

Indication: Lower resp tract infections eg, bronchitis & pneumonia, odontostomatological, skin & soft tissue infec...

2  /  22
2  /  22
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rhythm vs rate control in AF: A win finally?
Pearl Toh, 12 Sep 2020
Early initiation of rhythm-control therapy led to a significantly reduced risk of major adverse cardiovascular (CV) outcomes compared with usual care (typically rate control) in patients with newly diagnosed atrial fibrillation (AF) at risk of stroke, reveals the EAST-AFNET 4* trial presented at ESC 2020.
Can coronary plaque EVAPORATE with prescription-grade EPA?
Audrey Abella, 16 Sep 2020
The final results of EVAPORATE* reinforce the plaque-regressing potential of icosapent ethyl (IPE) in patients on statins for elevated triglycerides.